Top Markets
Coin of the day
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA

FSNUY
Rangering i aksjer #183
Fresenius SE & Co. KGaA, a health care company, provides products and services... Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Aksjekurs
$12.65
Markedsverdi
$114.00B
Endring (1 dag)
1.36%
Endring (1 år)
3.52%
Land
DE
Handel Fresenius SE & Co. KGaA (FSNUY)

Kategori

Inntekter for Fresenius SE & Co. KGaA (FSNUY)
Inntekter i Mar 2026 TTM: $2.56B
Ifølge Fresenius SE & Co. KGaA sine nyeste økonomiske rapporter er selskapets nåværende resultat $2.56B. I 2023 hadde selskapet et resultat på $790.41M, en nedgang sammenlignet med resultatet i 2022, som var $3.02B. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Fresenius SE & Co. KGaA fra 2002 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
2026 (TTM) $2.56B 77.12%
2024 $1.44B 82.73%
2023 $790.41M -73.81%
2022 $3.02B -25.42%
2021 $4.05B -10.81%
2020 $4.54B 3.39%
2019 $4.39B -18.11%
2018 $5.36B 13.43%
2017 $4.73B 19.92%
2016 $3.94B 11.25%
2015 $3.54B 16.54%
2014 $3.04B -8.18%
2013 $3.31B 4.95%
2012 $3.15B 26.11%
2011 $2.50B 4.74%
2010 $2.39B 15.41%
2009 $2.07B 33.27%
2008 $1.55B 0.00%
2007 0.00 0.00%
2006 0.00 0.00%
2005 0.00 0.00%
2004 0.00 -100.00%
2003 $669.93M 16.93%
2002 $572.95M 0.00%
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$9.79B 282.77%
US
$658.38M -74.26%
SA
$3.17B 23.80%
US
$861.87M -66.31%
CN
$1.40B -45.21%
US